Encompass Health Corporation (EHC)
- Previous Close
92.65 - Open
93.06 - Bid 92.00 x 800
- Ask 92.18 x 900
- Day's Range
91.84 - 93.59 - 52 Week Range
57.55 - 94.59 - Volume
94,060 - Avg. Volume
636,460 - Market Cap (intraday)
9.299B - Beta (5Y Monthly) 0.78
- PE Ratio (TTM)
22.87 - EPS (TTM)
4.04 - Earnings Date Oct 24, 2024 - Oct 28, 2024
- Forward Dividend & Yield 0.68 (0.73%)
- Ex-Dividend Date Oct 1, 2024
- 1y Target Est
100.91
Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions. It offers services through the Medicare program to federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. The company was incorporated in 1984 and is based in Birmingham, Alabama.
www.encompasshealth.com27,253
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: EHC
View MorePerformance Overview: EHC
Trailing total returns as of 9/23/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: EHC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: EHC
View MoreValuation Measures
Market Cap
9.32B
Enterprise Value
12.11B
Trailing P/E
22.93
Forward P/E
20.20
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.86
Price/Book (mrq)
5.07
Enterprise Value/Revenue
2.39
Enterprise Value/EBITDA
11.06
Financial Highlights
Profitability and Income Statement
Profit Margin
7.88%
Return on Assets (ttm)
8.09%
Return on Equity (ttm)
23.11%
Revenue (ttm)
5.07B
Net Income Avi to Common (ttm)
409M
Diluted EPS (ttm)
4.04
Balance Sheet and Cash Flow
Total Cash (mrq)
154.4M
Total Debt/Equity (mrq)
116.41%
Levered Free Cash Flow (ttm)
42.06M